Neurotensin is Metabolized by Endogenous Proteases in Prostate Cancer Cell Lines
- 1 February 1998
- Vol. 19 (2) , 253-258
- https://doi.org/10.1016/s0196-9781(97)00306-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of actionJournal of Clinical Endocrinology & Metabolism, 1993
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992
- Specificity of Neurotensin Metabolism by Regional Rat Brain SlicesJournal of Neurochemistry, 1992
- Neurotensin may function as a regulatory peptide in small cell lung cancerPeptides, 1991
- β-endorphin and neurotensin stimulate in vitro clonal growth of human SCLC cellsEuropean Journal of Pharmacology, 1989
- Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidaseBiochimie, 1988
- Neuroleptic drug treatment alters in vitro central neurotensin metabolismPsychoneuroendocrinology, 1987
- Peptidergic Innervation of the Human Male Genital TractJournal of Urology, 1983
- Degradation of Neurotensin by Rat Brain Synaptic Membranes: Involvement of a Thermolysin‐Like Metalloendopeptidase (Enkephalinase), Angiotensin‐Converting Enzyme, and Other Unidentified PeptidasesJournal of Neurochemistry, 1983
- Neurotensin: Antinocisponsive action in rodentsEuropean Journal of Pharmacology, 1979